Mudita Advisors LLP Maxcyte, Inc. Transaction History
Mudita Advisors LLP
- $170 Million
- Q4 2024
A detailed history of Mudita Advisors LLP transactions in Maxcyte, Inc. stock. As of the latest transaction made, Mudita Advisors LLP holds 3,223,407 shares of MXCT stock, worth $10.3 Million. This represents 7.89% of its overall portfolio holdings.
Number of Shares
3,223,407
Previous 3,153,441
2.22%
Holding current value
$10.3 Million
Previous $12.3 Million
9.32%
% of portfolio
7.89%
Previous 6.94%
Shares
10 transactions
Others Institutions Holding MXCT
# of Institutions
123Shares Held
69.8MCall Options Held
8.7KPut Options Held
6K-
Cadian Capital Management, LP New York, NY9.34MShares$29.8 Million2.26% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$26 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.43MShares$17.3 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$16.1 Million18.06% of portfolio
-
Morgan Stanley New York, NY4.41MShares$14.1 Million0.0% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $324M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...